According to Global Cord Blood's latest financial reports the company's current EPS (TTM) is ยฃ0.48. In 2021 the company made an earnings per share (EPS) of ยฃ0.50 an increase over its 2020 EPS that were of ยฃ0.43.
Year | EPS | Change |
---|---|---|
2022 (TTM) | ยฃ0.48 | -4.72% |
2021 | ยฃ0.50 | 16.43% |
2020 | ยฃ0.43 | 4.51% |
2019 | ยฃ0.41 | 90.64% |
2018 | ยฃ0.22 | -15.53% |
2017 | ยฃ0.26 | 74.71% |
2016 | ยฃ0.15 | -4.6% |
2015 | ยฃ0.15 | -20.5% |
2014 | ยฃ0.19 | 7.83% |
2013 | ยฃ0.18 | |
2009 | ยฃ0.008587 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
![]() Cryo-Cell CCEL | ยฃ0.23 | -52.21% | ๐บ๐ธ USA |
![]() NeoGenomics
NEO | -ยฃ0.46 | -194.85% | ๐บ๐ธ USA |
![]() RadNet RDNT | -ยฃ0.41 | -185.52% | ๐บ๐ธ USA |
![]() National Healthcare
NHC | ยฃ5.24 | 988.40% | ๐บ๐ธ USA |